Perspective Therapeutics (CATX) Interest Expenses (2010 - 2026)
Perspective Therapeutics recorded quarterly Interest Expenses of $105000.0 in Q1 2026, up 64.06% quarter-over-quarter from $64000.0 in Q4 2025, and down 17.97% year-over-year from $128000.0 in Q1 2025.
Perspective Therapeutics' Interest Expenses history runs 11 years deep, the most recent figure standing at $105000.0 for Q1 2026.
- In Q1 2026, Interest Expenses fell 17.97% year-over-year to $105000.0; the TTM figure through Mar 2026 stood at $353000.0 (up 140.14% YoY), while the FY2025 annual figure was $376000.0, up 683.33% from the prior year.
- Interest Expenses came in at $105000.0 for Q1 2026 at Perspective Therapeutics, up from $64000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $128000.0 in Q1 2025 to a low of -$73000.0 in Q4 2024.
- A 4-year average of $47000.0 and a median of $29000.0 in 2024 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses sank 404.17% in 2024 and soared 417.39% in 2025, its largest moves.
- Perspective Therapeutics' Interest Expenses stood at $24000.0 in 2023, then tumbled by 404.17% to -$73000.0 in 2024, then soared by 187.67% to $64000.0 in 2025, then soared by 64.06% to $105000.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $105000.0, $64000.0, and $65000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 174.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 181.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 90.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -97.17 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.10 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 105,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105,000.00 |
| Mar 31, 2026 | 105,000.00 |
| Dec 31, 2025 | 64,000.00 |
| Dec 31, 2025 | 64,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 119,000.00 |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | 128,000.00 |
| Mar 31, 2025 | 128,000.00 |
| Dec 31, 2024 | -73,000.00 |
| Dec 31, 2024 | -73,000.00 |
| Sep 30, 2024 | 69,000.00 |
| Sep 30, 2024 | 69,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Jun 30, 2016 | 50.00 |
| Jun 30, 2016 | 50.00 |
| Sep 30, 2015 | 950.00 |
| Sep 30, 2015 | 950.00 |
| Jun 30, 2015 | -1,551.00 |
| Jun 30, 2015 | -1,551.00 |
| Mar 31, 2015 | 100.00 |
| Mar 31, 2015 | 100.00 |
| Sep 30, 2014 | 3,451.00 |
| Sep 30, 2014 | 3,451.00 |
| Jun 30, 2014 | 56.00 |
| Jun 30, 2014 | 56.00 |
| Dec 31, 2013 | 86.00 |
| Dec 31, 2013 | 86.00 |
| Sep 30, 2013 | 741.00 |
| Sep 30, 2013 | 741.00 |
| Jun 30, 2013 | 1.00 |
| Jun 30, 2013 | 1.00 |
| Sep 30, 2012 | 6.00 |
| Sep 30, 2012 | 6.00 |
| Jun 30, 2012 | 55,359.00 |
| Jun 30, 2012 | 55,359.00 |
| Mar 31, 2012 | 3,266.00 |
| Mar 31, 2012 | 3,266.00 |
| Dec 31, 2011 | 2,962.00 |
| Dec 31, 2011 | 2,962.00 |
| Sep 30, 2011 | 94.00 |
| Sep 30, 2011 | 94.00 |
| Jun 30, 2011 | 23,106.00 |
| Jun 30, 2011 | 23,106.00 |
| Mar 31, 2011 | 174,675.00 |
| Mar 31, 2011 | 174,675.00 |
| Dec 31, 2010 | 14,412.00 |
| Dec 31, 2010 | 14,412.00 |
| Sep 30, 2010 | 4,463.00 |
| Sep 30, 2010 | 4,463.00 |